Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy

BACKGROUND: Liquid biopsies of blood plasma cell free DNA can be used to monitor treatment response and potentially detect mutations that are present in resistant clones in metastatic cancer patients. CASE PRESENTATION: In our non-interventional liquid biopsy study, a male patient in his fifties dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendricks, Alexander, Rosenstiel, Philip, Hinz, Sebastian, Burmeister, Greta, Röcken, Christoph, Boersch, Kathrin, Schafmayer, Clemens, Becker, Thomas, Franke, Andre, Forster, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942307/
https://www.ncbi.nlm.nih.gov/pubmed/31900123
http://dx.doi.org/10.1186/s12881-019-0941-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942307/
https://www.ncbi.nlm.nih.gov/pubmed/31900123
http://dx.doi.org/10.1186/s12881-019-0941-5

Ejemplares similares